# Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.

> **NCT04072874** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Universidad de Antioquia**

## Conditions studied

- Leishmaniasis, Cutaneous

## Interventions

- **DRUG:** Experimental topical (Curaleish Topical)

## Key facts

- **NCT ID:** NCT04072874
- **Lead sponsor:** Universidad de Antioquia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01
- **Primary completion:** 2021-02
- **Final completion:** 2022-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Tthe study is in the approval phase by local regulatory authorities
- **Last updated:** 2022-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04072874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04072874, "Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04072874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*